Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Standards of Care I

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:

Standards of Care II

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Current Trends in Nursing I

Current Trends in Nursing I

Current trends in nursing include:

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Are purely cosmetic procedures appropriate for the management of pectus excavatum? A qualitative study of pediatric surgeons.

Journal of pediatric surgery·2026

Same author

Principles of sustainable surgical and anesthetic practice.

Journal of pediatric surgery·2026

Same author

Environmental and human health impact of contact precaution use for methicillin-resistant <i>Staphylococcus aureus</i> and vancomycin-resistant <i>Enterococcus</i> in Los Angeles County.

Infection control and hospital epidemiology·2025

Same author

Expression of Concern for JAK2-binding long noncoding RNA promotes breast cancer brain metastasis.

The Journal of clinical investigation·2025

Same author

Sustainable surgery: Merging health care and environmental impact.

Surgery·2025

Same author

Reducing the carbon footprint of a laparoscopic appendectomy: A life cycle assessment.

Surgery·2025

Search research articles

Related Experiment Videos

Src continues aging: current and future clinical directions.

Scott Kopetz¹, Ami N Shah, Gary E Gallick

¹Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

|December 21, 2007

Summary

Aberrant Src kinase activation fuels solid tumors, prompting clinical trials for Src inhibitors. Further research is vital to optimize these targeted therapies for cancer treatment.

Related Experiment Videos

Area of Science:

Oncology
Molecular Biology
Pharmacology

Background:

Aberrant activation of Src family kinases is prevalent in solid tumors.
These kinases play a role in tumor development and progression.

Purpose of the Study:

To review the preclinical rationale for Src inhibitors.
To discuss clinical development strategies for Src inhibitors.
To explore the use of Src inhibitors in combination therapies.

Main Methods:

Review of preclinical data.
Analysis of clinical trial strategies.
Discussion of combination therapeutic approaches.

Main Results:

Four Src inhibitors are in over 50 clinical trials for solid tumors.
Src inhibitors show promise as targeted cancer therapies.

Conclusions:

Src inhibitors are a developing therapeutic strategy for solid tumors.
Further research is needed to understand Src kinase roles in tumor progression, chemoresistance, and epithelial-to-mesenchymal transition to refine clinical trial designs.